Enfusion Inc (ENFN) Insider Trading
- $21,447,098.00
- $58,223,939.12
- Jan. 13, 2025
- Dan Groman
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 13, 2025 | Director | 1,637 | $10.53 | Sell | $17,237.61 | |
| Jan. 7, 2025 | Insider | 809 | $10.13 | Sell | $8,195.17 | |
| Jan. 7, 2025 | General Counsel | 976 | $10.13 | Sell | $9,886.88 | |
| Jan. 7, 2025 | CEO | 2,771 | $10.13 | Sell | $28,070.23 | |
| Jan. 7, 2025 | CAO | 796 | $10.13 | Sell | $8,063.48 | |
| Jan. 7, 2025 | CFO | 4,134 | $10.13 | Sell | $41,877.42 | |
| Dec. 20, 2024 | CFO | 24,443 | $10.61 | Sell | $259,340.23 | |
| Dec. 2, 2024 | COO | 21,801 | $10.03 | Sell | $218,664.03 | |
| Oct. 22, 2024 | General Counsel | 674 | $8.95 | Sell | $6,032.30 | |
| June 20, 2024 | Insider | 18,241 | $8.11 | Sell | $147,934.51 | |
| June 14, 2024 | Director | 4,629 | $8.40 | Sell | $38,883.60 | |
| Feb. 29, 2024 | CAO | 27 | $8.73 | Sell | $235.71 | |
| Feb. 29, 2024 | General Counsel | 108 | $8.73 | Sell | $942.84 | |
| Jan. 10, 2024 | Director | 1,770 | $8.65 | Sell | $15,310.50 | |
| Jan. 8, 2024 | CEO | 1,295 | $9.23 | Sell | $11,952.85 | |
| Jan. 8, 2024 | CFO | 1,998 | $9.23 | Sell | $18,441.54 | |
| Jan. 8, 2024 | Insider | 391 | $9.23 | Sell | $3,608.93 | |
| Jan. 8, 2024 | General Counsel | 472 | $9.23 | Sell | $4,356.56 | |
| Dec. 14, 2023 | CEO | 100,000 | $10.01 | Sell | $1,001,000.00 | |
| Dec. 1, 2023 | CEO | 150,000 | $10.09 | Sell | $1,513,500.00 | |
| Nov. 27, 2023 | Major Shareholder | 1,000,000 | $9.86 | Sell | $9,860,000.00 | |
| Nov. 14, 2023 | CTO | 5,000 | $9.97 | Sell | $49,850.00 | |
| Oct. 17, 2023 | CTO | 5,000 | $9.09 | Sell | $45,450.00 | |
| Sept. 19, 2023 | CTO | 5,000 | $9.07 | Sell | $45,350.00 | |
| Aug. 14, 2023 | Insider | 41 | $7.89 | Sell | $323.49 | |
| Aug. 14, 2023 | CTO | 1,760 | $7.89 | Sell | $13,886.40 | |
| Aug. 11, 2023 | CTO | 1,850 | $8.10 | Sell | $14,985.00 | |
| Aug. 11, 2023 | Insider | 44 | $8.10 | Sell | $356.40 | |
| Aug. 9, 2023 | Insider | 55 | $8.32 | Sell | $457.60 | |
| Aug. 9, 2023 | CTO | 2,317 | $8.32 | Sell | $19,277.44 | |
| July 17, 2023 | CTO | 3,877 | $11.31 | Sell | $43,848.87 | |
| July 11, 2023 | Major Shareholder | 1,000,000 | $10.70 | Sell | $10,700,000.00 | |
| June 20, 2023 | CTO | 3,877 | $8.86 | Sell | $34,350.22 | |
| May 10, 2023 | CTO | 15,048 | $8.34 | Sell | $125,500.32 | |
| April 17, 2023 | CTO | 3,877 | $9.66 | Sell | $37,451.82 | |
| March 17, 2023 | CTO | 3,877 | $10.94 | Sell | $42,414.38 | |
| March 8, 2023 | Major Shareholder | 1,000,000 | $11.35 | Sell | $11,350,000.00 | |
| Jan. 17, 2023 | CTO | 3,877 | $10.93 | Sell | $42,375.61 | |
| Nov. 11, 2022 | Major Shareholder | 1,000,000 | $12.15 | Sell | $12,150,000.00 | |
| Oct. 25, 2021 | Director | 1,261,594 | $17.00 | Buy | $21,447,098.00 | |
| Oct. 25, 2021 | Major Shareholder | 647,862 | $15.89 | Sell | $10,294,527.18 |
Insiders are both buying and selling Enfusion Inc stock.
The insider traders at Enfusion Inc are: Dan Groman, Bronwen Bastone, Oleg Movchan, Matthew Campobasso, Deirdre Somers, Bradley Herring, Valeria Gutowski, Stephen Malherbe, Tarek Hammoud, Hillhouse Investment Managemen, Neal Pawar, and Roy Luo
The most active insider trader at Enfusion Inc is Dan Groman with 12 trades.
Tarek Hammoud has sold the most Enfusion Inc stock with a total value of $33,550,000.00.
Roy Luo has bought the most Enfusion Inc stock with a total value of $42,894,196.00.
The most recent insider trade for Enfusion Inc was on Jan. 13, 2025.
The single biggest insider buy for Enfusion Inc was from Roy Luo with a total value of $21,447,098.00 on Oct. 25, 2021.
The single biggest insider sell for Enfusion Inc was from Tarek Hammoud with a total value of $12,150,000.00 on Nov. 11, 2022.